Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Dyes
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Dyes

[0271-22645] LysoBrite Red (lysosome staining dye for live cells) - 500 reactions
LysoBrite Red (lysosome staining dye for live cells) - 500 reactions
320.00 € 320.0 EUR
[0037-32004-T] Live-or-Dye Fixable Viability Staining Tests - 50 assays, Live-or-Dye 488/515
Live-or-Dye Fixable Viability Staining Tests - 50 assays, Live-or-Dye 488/515
130.27 € 130.27 EUR
[0037-32007] Live-or-Dye Fixable Viability Staining Tests - 200 assays, Live-or-Dye 640/662
Live-or-Dye Fixable Viability Staining Tests - 200 assays, Live-or-Dye 640/662
325.00 € 325.0 EUR
[0037-32003] Live-or-Dye Fixable Viability Staining Test (405/452) - 200 assays
Live-or-Dye Fixable Viability Staining Test (405/452) - 200 assays
424.00 € 424.0 EUR
[0037-32002-200T] Live-or-Dye 350/448 (200 assays)
Live-or-Dye 350/448 (200 assays)
397.70 € 397.7 EUR
[0542-ACT-IDmG.04] HydraGreen Safe DNA Dye - 1ml (400x 50ml or 200x 100ml agarose gels)
HydraGreen Safe DNA Dye - 1ml (400x 50ml or 200x 100ml agarose gels)
404.00 € 404.0 EUR
[0999-12102] QuDye dsDNA HS Assay Test,  100 assays
QuDye dsDNA HS Assay Test, 100 assays
279.00 € 279.0 EUR
[0037-40069] PMAxx Dye, 20 mM in H2O, 100 ul
PMAxx Dye, 20 mM in H2O, 100 ul
292.00 € 292.0 EUR
[0037-00005] α-Bungarotoxin, CF® Dye and Other Conjug.ates CF488A, 0.5mG.
α-Bungarotoxin, CF® Dye and Other Conjug.ates CF488A, 0.5mG.
749.00 € 749.0 EUR
[0037-33016] Tyramide Amplification Test with HRP Goat Anti-Rabbit and CF® Dye or Biotin Tyramide, CF680R, 1 Test
Tyramide Amplification Test with HRP Goat Anti-Rabbit and CF® Dye or Biotin Tyramide, CF680R, 1 Test
849.00 € 849.0 EUR
  • 1
  • 2
  • 3

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)